Ganglion AI - About the company
Ganglion AI is an unfunded company. It operates as a Developer of mobile pupillary screening application for concussion and brain injury. Ganglion AI has not raised any funding yet. The company has 418 active competitors, including 41 funded and 30 that have exited. Its top competitors include companies like Axis Care, Remepy and Allocate Software.
Company Details
Developer of mobile pupillary screening application for concussion and brain injury. The application facilitates pupillary light response monitoring for neurocritical patients. It offers physicians objective metrics to determine traumatic brain injury or increased intracranial pressure. The application also assists in rapid concussion testing for athletes.
Key Metrics
Sign up to download Ganglion AI's company profile
Ganglion AI's funding and investors
Ganglion AI has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ganglion AI's Competitors and alternates
Top competitors of Ganglion AI include Axis Care, Remepy and Allocate Software. Here is the list of Top 10 competitors of Ganglion AI, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Axis Care 2015, Austin (United States), Seed | Provider of software for home care agency management and operations | - | 56/100 | |
2nd | Remepy 2022, United States, Series A | Provider of healthcare software application services | $62M | 51/100 | |
3rd | Allocate Software 1991, Richmond (United Kingdom), Acquired | Developer of software that aims to improve healthcare delivery standards | - | 44/100 | |
4th | Nirmitee 2020, Iselin (United States), Unfunded | Provider of enterprise software solutions specializing in ERP and digital transformation | - | - | 44/100 |
5th | Baracoda Daily Healthtech is a global leader in IoT healthtech, empowering users to take charge of their health through connected products | - | - | 42/100 | |
6th | Significo 2014, Austin (United States), Series B | Provider of software development services | $12M | 41/100 | |
7th | Sequenex 2020, San Diego (United States), Unfunded | Developer of medical device software and SaMD solutions | - | - | 41/100 |
8th | Designer & operator of WEB media, planning, and development of child-rearing support apps | - | - | 40/100 | |
9th | Provider of software solutions | - | 40/100 | ||
10th | Dash Technologies 2010, Columbus (United States), Unfunded | Developer of software engineering and data analytics for healthcare organizations | - | - | 38/100 |
363rd | ![]() Ganglion AI Unfunded | Developer of mobile pupillary screening application for concussion and brain injury | - | - | 16/100 |
Looking for more details on Ganglion AI's competitors? Click here to see the top ones
Ganglion AI's Investments and acquisitions
Ganglion AI has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Ganglion AI
Explore our recently published companies
- Economic Space - Indonesia based, Unfunded company
- Curio - 2024 founded, Unfunded company
- Prosprous - 2024 founded, Unfunded company
- Maloka - Manaus based, 2024 founded, Unfunded company
- DecisiveAI - Morocco based, 2025 founded, Unfunded company
- KEEPON - New York City based, 2025 founded, Unfunded company
